On the public citation graph

Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment

https://doi.org/10.1002/smll.202300666

0 signed · 220 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adhm.201901858openalex-snapshot

Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy

inferredcites →https://doi.org/10.1002/advs.202000915openalex-snapshot

Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/β‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy

inferredcites →https://doi.org/10.1002/btm2.10284openalex-snapshot

Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer

inferredcites →https://doi.org/10.1002/cncr.21324openalex-snapshot

The role of radiotherapy in cancer treatment

inferredcites →https://doi.org/10.1002/psc.3145openalex-snapshot

The penetrating properties of the tumor homing peptide LyP‐1 in model lipid membranes

inferredcites →https://doi.org/10.1007/s00280-019-03910-6openalex-snapshot

Current status of nanomedicine in the chemotherapy of breast cancer

inferredcites →https://doi.org/10.1007/s10549-007-9591-yopenalex-snapshot

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

inferredcites →https://doi.org/10.1007/s11060-010-0389-0openalex-snapshot

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

inferredcites →https://doi.org/10.1007/s12010-018-2773-8openalex-snapshot

Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.1007/s12015-019-09944-wopenalex-snapshot

Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity

inferredcites →https://doi.org/10.1007/s12015-020-10089-4openalex-snapshot

Delivery of miR-381-3p Mimic by Mesenchymal Stem Cell-Derived Exosomes Inhibits Triple Negative Breast Cancer Aggressiveness; an In Vitro Study

inferredcites →https://doi.org/10.1007/s40265-020-01295-yopenalex-snapshot

Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.1016/j.actbio.2017.09.016openalex-snapshot

Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity

inferredcites →https://doi.org/10.1016/j.actbio.2018.12.007openalex-snapshot

Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy

inferredcites →https://doi.org/10.1016/j.actbio.2019.05.054openalex-snapshot

Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery

inferredcites →https://doi.org/10.1016/j.actbio.2021.09.003openalex-snapshot

Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis

inferredcites →https://doi.org/10.1016/j.addr.2016.03.008openalex-snapshot

Tumor penetrating peptides for improved drug delivery

inferredcites →https://doi.org/10.1016/j.addr.2021.114034openalex-snapshot

Current understandings and clinical translation of nanomedicines for breast cancer therapy

inferredcites →https://doi.org/10.1016/j.apsb.2021.12.021openalex-snapshot

Emerging vaccine nanotechnology: From defense against infection to sniping cancer

inferredcites →https://doi.org/10.1016/j.arabjc.2017.05.011openalex-snapshot

Nanoparticles: Properties, applications and toxicities

inferredcites →https://doi.org/10.1016/j.bbamcr.2007.04.015openalex-snapshot

Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity

inferredcites →https://doi.org/10.1016/j.bbcan.2021.188624openalex-snapshot

New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies

inferredcites →https://doi.org/10.1016/j.bioactmat.2022.08.028openalex-snapshot

A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody

inferredcites →https://doi.org/10.1016/j.biomaterials.2013.04.025openalex-snapshot

Glioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxel

inferredcites →https://doi.org/10.1016/j.biomaterials.2013.11.083openalex-snapshot

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy

inferredcites →https://doi.org/10.1016/j.biomaterials.2018.05.048openalex-snapshot

Development and MPI tracking of novel hypoxia-targeted theranostic exosomes

inferredcites →https://doi.org/10.1016/j.biomaterials.2019.01.007openalex-snapshot

Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer

inferredcites →https://doi.org/10.1016/j.biomaterials.2020.119769openalex-snapshot

Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model

inferredcites →https://doi.org/10.1016/j.biomaterials.2020.120224openalex-snapshot

An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition

inferredcites →https://doi.org/10.1016/j.biomaterials.2021.120709openalex-snapshot

Nanobiomaterial-based vaccination immunotherapy of cancer

inferredcites →https://doi.org/10.1016/j.biomaterials.2021.120716openalex-snapshot

Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis

inferredcites →https://doi.org/10.1016/j.biopha.2020.110876openalex-snapshot

Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity

inferredcites →https://doi.org/10.1016/j.breast.2013.10.006openalex-snapshot

Emerging nanotherapeutic strategies in breast cancer

inferredcites →https://doi.org/10.1016/j.canlet.2014.04.003openalex-snapshot

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug

inferredcites →https://doi.org/10.1016/j.canlet.2019.12.046openalex-snapshot

Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?

inferredcites →https://doi.org/10.1016/j.canlet.2022.215781openalex-snapshot

Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis

inferredcites →https://doi.org/10.1016/j.carres.2020.108032openalex-snapshot

Hyaluronan decoration of milk exosomes directs tumor-specific delivery of doxorubicin

inferredcites →https://doi.org/10.1016/j.chemphyslip.2020.104882openalex-snapshot

Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer

inferredcites →https://doi.org/10.1016/j.ijpharm.2019.118595openalex-snapshot

Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6

inferredcites →https://doi.org/10.1016/j.imbio.2006.11.011openalex-snapshot

The contribution of gC1qR/p33 in infection and inflammation

inferredcites →https://doi.org/10.1016/j.imlet.2021.08.004openalex-snapshot

TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice

inferredcites →https://doi.org/10.1016/j.immuni.2016.02.004openalex-snapshot

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

inferredcites →https://doi.org/10.1016/j.intimp.2020.107198openalex-snapshot

Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line

inferredcites →https://doi.org/10.1016/j.jbiotec.2013.03.013openalex-snapshot

Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection

inferredcites →https://doi.org/10.1016/j.jconrel.2012.03.020openalex-snapshot

Doxil® — The first FDA-approved nano-drug: Lessons learned

inferredcites →https://doi.org/10.1016/j.jconrel.2014.07.042openalex-snapshot

Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery

inferredcites →https://doi.org/10.1016/j.jconrel.2018.10.030openalex-snapshot

Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer

inferredcites →https://doi.org/10.1016/j.jconrel.2019.12.005openalex-snapshot

Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis

inferredcites →https://doi.org/10.1016/j.lfs.2021.119800openalex-snapshot

Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages

inferredcites →https://doi.org/10.1016/j.lfs.2021.120015openalex-snapshot

Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells

inferredcites →https://doi.org/10.1016/j.msec.2020.111847openalex-snapshot

Targeted-delivery of siRNA via a polypeptide-modified liposome for the treatment of gp96 over-expressed breast cancer

inferredcites →https://doi.org/10.1016/j.mtadv.2022.100252openalex-snapshot

Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy

inferredcites →https://doi.org/10.1016/j.nano.2019.02.008openalex-snapshot

Immunostimulatory cytokine and doxorubicin co-loaded nanovesicles for cancer immunochemotherapy

inferredcites →https://doi.org/10.1016/j.trecan.2020.04.008openalex-snapshot

Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic

inferredcites →https://doi.org/10.1016/j.ymthe.2017.10.020openalex-snapshot

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer

inferredcites →https://doi.org/10.1016/j.ymthe.2022.06.013openalex-snapshot

Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes

inferredcites →https://doi.org/10.1016/s0140-6736(16)32454-0openalex-snapshot

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

inferredcites →https://doi.org/10.1016/s1470-2045(15)00222-3openalex-snapshot

Expanding global access to radiotherapy

inferredcites →https://doi.org/10.1021/acs.biomac.9b00788openalex-snapshot

Two-Way Cruise Nanosatellite Promotes Metastasis Inhibition by Immunochemotherapy

inferredcites →https://doi.org/10.1021/acs.molpharmaceut.6b01148openalex-snapshot

Functionalized Lipid–Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes

inferredcites →https://doi.org/10.1021/acs.molpharmaceut.8b01065openalex-snapshot

Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1–/FOXM1+ Triple Negative Breast Cancer Cells

inferredcites →https://doi.org/10.1021/acs.molpharmaceut.9b00104openalex-snapshot

Exosomes as Drug Carriers for Cancer Therapy

inferredcites →https://doi.org/10.1021/acs.nanolett.0c01140openalex-snapshot

Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer

inferredcites →https://doi.org/10.1021/acs.nanolett.1c01210openalex-snapshot

Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages

inferredcites →https://doi.org/10.1021/acs.nanolett.2c00500openalex-snapshot

Surgical Tumor-Derived Photothermal Nanovaccine for Personalized Cancer Therapy and Prevention

inferredcites →https://doi.org/10.1021/acs.nanolett.8b04296openalex-snapshot

Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD‑1 Therapy

inferredcites →https://doi.org/10.1021/acsabm.2c00015openalex-snapshot

Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells

inferredcites →https://doi.org/10.1021/acsami.0c06120openalex-snapshot

Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy

inferredcites →https://doi.org/10.1021/acsami.8b22309openalex-snapshot

Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells

inferredcites →https://doi.org/10.1021/acsnano.0c05194openalex-snapshot

Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors

inferredcites →https://doi.org/10.1021/acsnano.2c06560openalex-snapshot

In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy

inferredcites →https://doi.org/10.1021/acsnano.8b00967openalex-snapshot

Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers

inferredcites →https://doi.org/10.1021/acsnano.8b02038openalex-snapshot

Synergistically Enhancing the Therapeutic Effect of Radiation Therapy with Radiation Activatable and Reactive Oxygen Species-Releasing Nanostructures

inferredcites →https://doi.org/10.1021/nn507465dopenalex-snapshot

Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy

inferredcites →https://doi.org/10.1038/aps.2016.166openalex-snapshot

Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice

inferredcites →https://doi.org/10.1038/cdd.2009.206openalex-snapshot

Granzymes in cancer and immunity

inferredcites →https://doi.org/10.1038/mt.2012.180openalex-snapshot

Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells

inferredcites →https://doi.org/10.1038/ncb2000openalex-snapshot

Rab27a and Rab27b control different steps of the exosome secretion pathway

inferredcites →https://doi.org/10.1038/nmeth.4185openalex-snapshot

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

inferredcites →https://doi.org/10.1038/nrc.2016.108openalex-snapshot

Cancer nanomedicine: progress, challenges and opportunities

inferredcites →https://doi.org/10.1038/nrc1566openalex-snapshot

Cancer nanotechnology: opportunities and challenges

inferredcites →https://doi.org/10.1038/nrc1670openalex-snapshot

Breast cancer metastasis: markers and models

inferredcites →https://doi.org/10.1038/nrclinonc.2016.66openalex-snapshot

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

inferredcites →https://doi.org/10.1038/nrclinonc.2017.149openalex-snapshot

Cancer vaccines on the move

inferredcites →https://doi.org/10.1038/nrd1088openalex-snapshot

The dawning era of polymer therapeutics

inferredcites →https://doi.org/10.1038/s12276-019-0223-5openalex-snapshot

Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking

inferredcites →https://doi.org/10.1038/s41419-017-0030-7openalex-snapshot

MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1

inferredcites →https://doi.org/10.1038/s41467-018-06893-9openalex-snapshot

Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance

inferredcites →https://doi.org/10.1038/s41467-019-11718-4openalex-snapshot

Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy

inferredcites →https://doi.org/10.1038/s41556-018-0250-9openalex-snapshot

Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication

inferredcites →https://doi.org/10.1038/s41563-019-0566-2openalex-snapshot

The entry of nanoparticles into solid tumours

inferredcites →https://doi.org/10.1038/s41565-020-00781-4openalex-snapshot

A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy

inferredcites →https://doi.org/10.1038/s41573-020-0090-8openalex-snapshot

Engineering precision nanoparticles for drug delivery

inferredcites →https://doi.org/10.1038/s41598-017-10062-1openalex-snapshot

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors

inferredcites →https://doi.org/10.1038/s41598-020-72268-0openalex-snapshot

Iodine nanoparticle radiotherapy of human breast cancer growing in the brains of athymic mice

inferredcites →https://doi.org/10.1038/s41598-021-04316-2openalex-snapshot

Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer

inferredcites →https://doi.org/10.1038/s41598-021-87968-4openalex-snapshot

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model

inferredcites →https://doi.org/10.1039/c9bm00393bopenalex-snapshot

Chitosan/poly(γ-glutamic acid) nanoparticles incorporating IFN-γ for immune response modulation in the context of colorectal cancer

inferredcites →https://doi.org/10.1039/c9tb00433eopenalex-snapshot

Improved tumor targeting and penetration by a dual-functional poly(amidoamine) dendrimer for the therapy of triple-negative breast cancer

inferredcites →https://doi.org/10.1039/d0nr00523aopenalex-snapshot

Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer

inferredcites →https://doi.org/10.1039/d1nr05385jopenalex-snapshot

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

inferredcites →https://doi.org/10.1042/bsr20171357openalex-snapshot

Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer

inferredcites →https://doi.org/10.1049/iet-nbt.2018.5137openalex-snapshot

Cytotoxicity investigations of biogenic tellurium nanorods towards PC12 cell line

inferredcites →https://doi.org/10.1056/nejmoa1809615openalex-snapshot

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.1080/02656736.2019.1685686openalex-snapshot

Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer

inferredcites →https://doi.org/10.1080/14760584.2018.1434000openalex-snapshot

Current challenges for cancer vaccine adjuvant development

inferredcites →https://doi.org/10.1080/15384047.2020.1861923openalex-snapshot

Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer

inferredcites →https://doi.org/10.1080/2162402x.2015.1071008openalex-snapshot

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

inferredcites →https://doi.org/10.1083/jcb.201212113openalex-snapshot

Exosomes: Looking back three decades and into the future

inferredcites →https://doi.org/10.1088/1361-6528/ab94dcopenalex-snapshot

Paclitaxel/sunitinib-loaded micelles promote an antitumor response in vitro through synergistic immunogenic cell death for triple-negative breast cancer

inferredcites →https://doi.org/10.1111/cas.14181openalex-snapshot

Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells

inferredcites →https://doi.org/10.1111/jcmm.17161openalex-snapshot

MicroRNA‐381 in human cancer: Its involvement in tumour biology and clinical applications potential

inferredcites →https://doi.org/10.1126/sciadv.aav5010openalex-snapshot

Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis

inferredcites →https://doi.org/10.1126/science.1203486openalex-snapshot

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

inferredcites →https://doi.org/10.1126/science.1203543openalex-snapshot

A Perspective on Cancer Cell Metastasis

inferredcites →https://doi.org/10.1126/science.aau6977openalex-snapshot

The biology , function , and biomedical applications of exosomes

inferredcites →https://doi.org/10.1126/scisignal.2005231openalex-snapshot

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells

inferredcites →https://doi.org/10.1126/scitranslmed.abl3649openalex-snapshot

Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice

inferredcites →https://doi.org/10.1128/mcb.01101-09openalex-snapshot

Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation

inferredcites →https://doi.org/10.1136/bmjopen-2018-023591openalex-snapshot

Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol

inferredcites →https://doi.org/10.1146/annurev-cellbio-101512-122326openalex-snapshot

Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles

inferredcites →https://doi.org/10.1148/radiol.2021203476openalex-snapshot

Breast Cancer Mortality Rates Have Stopped Declining in U.S. Women Younger than 40 Years

inferredcites →https://doi.org/10.1152/ajpregu.00209.2018openalex-snapshot

Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment

inferredcites →https://doi.org/10.1155/2020/6272498openalex-snapshot

Tumor‐Derived Exosomes in Immunosuppression and Immunotherapy

inferredcites →https://doi.org/10.1158/0008-5472.can-06-3456openalex-snapshot

Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2

inferredcites →https://doi.org/10.1158/0008-5472.can-17-0994openalex-snapshot

The Biology of Cancer Exosomes: Insights and New Perspectives

inferredcites →https://doi.org/10.1158/0008-5472.can-18-3014openalex-snapshot

A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.1158/0008-5472.can-19-0381openalex-snapshot

Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity

inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-3045openalex-snapshot

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

inferredcites →https://doi.org/10.1161/circresaha.116.309115openalex-snapshot

Decline in Cardiovascular Mortality

inferredcites →https://doi.org/10.1172/jci.insight.120638openalex-snapshot

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

inferredcites →https://doi.org/10.1172/jci80009openalex-snapshot

Therapeutic cancer vaccines

inferredcites →https://doi.org/10.1186/1471-2407-8-42openalex-snapshot

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer

inferredcites →https://doi.org/10.1186/1476-4598-10-117openalex-snapshot

Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells

inferredcites →https://doi.org/10.1186/1479-5876-3-10openalex-snapshot

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

inferredcites →https://doi.org/10.1186/s12885-021-08441-zopenalex-snapshot

A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer

inferredcites →https://doi.org/10.1186/s12943-022-01515-xopenalex-snapshot

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

inferredcites →https://doi.org/10.1186/s12951-019-0526-7openalex-snapshot

Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy

inferredcites →https://doi.org/10.1186/s12951-022-01526-2openalex-snapshot

Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer

inferredcites →https://doi.org/10.1186/s13045-015-0181-xopenalex-snapshot

Exosomes in cancer: small particle, big player

inferredcites →https://doi.org/10.1186/s13578-020-00396-1openalex-snapshot

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

inferredcites →https://doi.org/10.1208/s12249-022-02349-yopenalex-snapshot

Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer

inferredcites →https://doi.org/10.1517/14656566.3.12.1739openalex-snapshot

Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy

inferredcites →https://doi.org/10.1667/rr14315.1openalex-snapshot

Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer

inferredcites →https://doi.org/10.18632/aging.203131openalex-snapshot

Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer

inferredcites →https://doi.org/10.2147/ijn.s123437openalex-snapshot

Nanomedicine applications in the treatment of breast cancer: current state of the art

inferredcites →https://doi.org/10.2147/ijn.s182384openalex-snapshot

Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo

inferredcites →https://doi.org/10.2147/ijn.s207837openalex-snapshot

Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene

inferredcites →https://doi.org/10.2147/ijn.s296513openalex-snapshot

Combined Photothermal and Ionizing Radiation Sensitization of Triple-Negative Breast Cancer Using Triangular Silver Nanoparticles

inferredcites →https://doi.org/10.2147/ijn.s346044openalex-snapshot

Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy

inferredcites →https://doi.org/10.2147/ijn.s596openalex-snapshot

Drug delivery and nanoparticles: Applications and hazards

inferredcites →https://doi.org/10.2147/ott.s173110openalex-snapshot

Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle

inferredcites →https://doi.org/10.2174/0929867328666210902141257openalex-snapshot

Gold Nanoparticles in Triple-Negative Breast Cancer Therapeutics

inferredcites →https://doi.org/10.2174/1567201814666170712122508openalex-snapshot

Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment

inferredcites →https://doi.org/10.2217/nnm-2020-0003openalex-snapshot

Phenyl Boronic Acid-Modified Lipid Nanocarriers of Niclosamide for Targeting Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.2217/nnm.14.144openalex-snapshot

Enhancement of Anti-Tumor Effect of Particulate Vaccine Delivery System by ‘Bacteriomimetic’ CpG Functionalization of Poly-Lactic-Co-glycolic Acid Nanoparticles

inferredcites →https://doi.org/10.2217/nnm.15.213openalex-snapshot

Rationalizing the Use of Functionalized Poly-Lactic-Co-Glycolic Acid Nanoparticles for Dendritic Cell-Based Targeted Anticancer Therapy

inferredcites →https://doi.org/10.3322/caac.21654openalex-snapshot

Cancer Statistics, 2021

inferredcites →https://doi.org/10.3322/caac.21660openalex-snapshot

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

inferredcites →https://doi.org/10.3389/fbioe.2020.01010openalex-snapshot

Tumor Exosome Mimicking Nanoparticles for Tumor Combinatorial Chemo-Photothermal Therapy

inferredcites →https://doi.org/10.3389/fmolb.2022.1022725openalex-snapshot

The application of exosomes in the treatment of triple-negative breast cancer

inferredcites →https://doi.org/10.3389/fmolb.2022.903065openalex-snapshot

Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities

inferredcites →https://doi.org/10.3389/pore.2022.1610378openalex-snapshot

Radiotherapy of Breast Cancer—Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

inferredcites →https://doi.org/10.3390/cancers12123773openalex-snapshot

Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators

inferredcites →https://doi.org/10.3390/cancers13030473openalex-snapshot

The Interplay of Exosomes and NK Cells in Cancer Biology

inferredcites →https://doi.org/10.3390/cancers13040898openalex-snapshot

CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.3390/cancers14163842openalex-snapshot

Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review

inferredcites →https://doi.org/10.3390/ijms18122702openalex-snapshot

The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms

inferredcites →https://doi.org/10.3390/ijms20194684openalex-snapshot

Challenges in Exosome Isolation and Analysis in Health and Disease

inferredcites →https://doi.org/10.3390/ijms21010273openalex-snapshot

Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications

inferredcites →https://doi.org/10.3390/ijms21176018openalex-snapshot

Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment

inferredcites →https://doi.org/10.3390/ijms23052856openalex-snapshot

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management

inferredcites →https://doi.org/10.3390/ijms231710068openalex-snapshot

Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy

inferredcites →https://doi.org/10.3390/molecules25112670openalex-snapshot

Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model

inferredcites →https://doi.org/10.3390/pharmaceutics12020096openalex-snapshot

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells

inferredcites →https://doi.org/10.3390/pharmaceutics13111829openalex-snapshot

Targeting Engineered Nanoparticles for Breast Cancer Therapy

inferredcites →https://doi.org/10.34172/bi.2021.27openalex-snapshot

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy

inferredcites →https://doi.org/10.3892/or.2017.5714openalex-snapshot

Exosomes: New players in cancer

inferredcites →https://doi.org/10.4049/jimmunol.166.12.7309openalex-snapshot

Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles

inferredcites →https://doi.org/10.4103/0971-5916.159250openalex-snapshot

Survivin: A molecular biomarker in cancer

inferredcites →https://doi.org/10.4103/0974-2727.163129openalex-snapshot

Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas

inferredcites →https://doi.org/10.4149/neo_2020_190601n478openalex-snapshot

Heat shock protein gp96 and CD4+ and CD8+ T-lymphocytes expression as prognostic factors in various molecular types of invasive breast carcinoma

inferredcites →https://doi.org/10.4155/fmc-2018-0417openalex-snapshot

Exosome Manufacturing Status

inferredcites →https://doi.org/10.4161/cc.21194openalex-snapshot

The role of S6K1 in ER-positive breast cancer

inferredcites →https://doi.org/10.7150/thno.30716openalex-snapshot

Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation

inferredcites →https://doi.org/10.7150/thno.35900openalex-snapshot

A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4654255openalex-extracted

Trim4 Promotes Small-Molecule-Induced CORO1A Neddylated-Degradation for Triple Negative Breast Cancer Therapy

inferred← citeshttps://doi.org/10.1002/adhm.202503039openalex-snapshot

Co‐Delivery Evodiamine‐Porphyrin Nano‐Drug to Enhance Photodynamic‐Chemo‐Immunotherapy for Triple‐Negative Breast Cancer Treatment

inferred← citeshttps://doi.org/10.1002/cam4.70803openalex-snapshot

Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements

inferred← citeshttps://doi.org/10.1002/mba2.70012openalex-snapshot

Beyond Conventional Approaches: The Revolutionary Role of Nanoparticles in Breast Cancer

inferred← citeshttps://doi.org/10.1002/smll.202403861openalex-snapshot

Photo‐Activated Oxidative Stress Amplifier: A Strategy for Targeting Glutathione Metabolism and Enhancing ROS‐Mediated Therapy in Triple‐Negative Breast Cancer Treatment

inferred← citeshttps://doi.org/10.1002/smll.202405178openalex-snapshot

Nanomedicine for Women's Health

inferred← citeshttps://doi.org/10.1002/tcr.202400171openalex-snapshot

Targeted Nanoprobes Enabled Precision Theranostics in Triple‐Negative Breast Cancer

inferred← citeshttps://doi.org/10.1007/s13346-024-01704-9openalex-snapshot

Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024

inferred← citeshttps://doi.org/10.1016/b978-0-443-21752-4.00006-7openalex-snapshot

Endogenous, natural, and synthetic antioxidants stabilize charnolosome and its exocytosis to confer theranostic benefit by inflammasome inhibition

inferred← citeshttps://doi.org/10.1016/b978-0-443-33343-9.00005-3openalex-snapshot

Nanotechnology for combating chemoresistance in peripheral cancers

inferred← citeshttps://doi.org/10.1016/j.bioadv.2024.213832openalex-snapshot

ROS mediated Cu[Fe(CN)5NO] nanoparticles for triple negative breast cancer: A detailed study in preclinical mouse model

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e25477openalex-snapshot

The utilization of nanotechnology in the female reproductive system and related disorders

inferred← citeshttps://doi.org/10.1016/j.isci.2025.112860openalex-snapshot

Mechanistic study of N-acetyltransferase 10 deficiency enhancing olaparib sensitivity in triple negative breast cancer by inhibiting RAD51 N4-acetylcytidine modification

inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.10.012openalex-snapshot

Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis

inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.113620openalex-snapshot

Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy

inferred← citeshttps://doi.org/10.1016/j.lfs.2023.122332openalex-snapshot

Extracellular vesicles-associated miRNAs in triple-negative breast cancer: from tumor biology to clinical relevance

inferred← citeshttps://doi.org/10.1016/j.snb.2025.139415openalex-snapshot

Polyvalent aptamer nanodrug constructed from nucleus-targeted iron-doped red carbon dots combined with rolling circle amplification for achieving effective cancer synergistic theranostics

inferred← citeshttps://doi.org/10.1021/acsami.4c08842openalex-snapshot

Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy

inferred← citeshttps://doi.org/10.1021/acsmaterialslett.3c00965openalex-snapshot

V 2 C-Driven Nanodelivery Platform Potentiates Synergistic Breast Cancer Therapy

inferred← citeshttps://doi.org/10.1039/d3nj03739hopenalex-snapshot

A multimodal therapeutic nano-prodrug as an oxidative stress amplifier induces apoptosis and ferroptosis for cancer therapy

inferred← citeshttps://doi.org/10.1080/15257770.2025.2524468openalex-snapshot

Aptamer-directed siRNA delivery systems for triple-negative breast cancer therapy

inferred← citeshttps://doi.org/10.1186/s11671-024-04089-3openalex-snapshot

The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date)

inferred← citeshttps://doi.org/10.1186/s12951-024-02308-8openalex-snapshot

Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC

inferred← citeshttps://doi.org/10.1186/s12951-025-03898-7openalex-snapshot

Nanotechnology for reproductive healthcare: a comprehensive review

inferred← citeshttps://doi.org/10.1186/s12951-025-03914-wopenalex-snapshot

Low-intensity pulsed ultrasound (LIPUS)-augmented calcicoptosis by calcium-based nanoparticles for enhanced immunogenic cell death induction in triple-negative breast cancer

inferred← citeshttps://doi.org/10.14715/cmb/2025.71.7.10openalex-snapshot

LINC01232 regulates miR-516a-5p/BCL9 axis to promote triple-negative breast cancer progression

inferred← citeshttps://doi.org/10.32628/ijsrset25121162openalex-snapshot

Nanoengineered Copper: Revolutionizing Breast Cancer Care

inferred← citeshttps://doi.org/10.3389/fimmu.2024.1384946openalex-snapshot

The involvement and application potential of exosomes in breast cancer immunotherapy

inferred← citeshttps://doi.org/10.3390/pharmaceutics17050640openalex-snapshot

Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives

inferred← citeshttps://doi.org/10.4018/979-8-3373-0055-9.ch007openalex-snapshot

Transformative Approaches in Breast Cancer Treatment

inferred← citeshttps://doi.org/10.4018/979-8-3373-9715-3.ch006openalex-snapshot

Omics-Nano-CRISPR Strategies for Combating Breast Cancer in the AI Age

inferred← citeshttps://doi.org/10.51189/conbiotec2024/31246openalex-snapshot

EXOSSOMAS COMO FERRAMENTA ESTRATÉGICA NA PESQUISA E DESENVOLVIMENTO DE VACINAS PARA O CÂNCER DE MAMA

inferred← citeshttps://doi.org/10.6084/m9.figshare.26691235openalex-snapshot

Additional file 1 of Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC

inferred← citeshttps://doi.org/10.7150/thno.97662openalex-snapshot

TRIM4 enhances small-molecule-induced neddylated-degradation of CORO1A for triple negative breast cancer therapy

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.